MLSS MILESTONE SCIENTIFIC

Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

ROSELAND, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will present at the Dawson James Securities Small Cap Growth Conference being held on October 21, 2021 at the Wyndham Grand Hotel in Jupiter, Florida.

Mr. Haverhals will present on Thursday, October 21st at 1:10 pm Eastern Time and will also be participating in one-on-one meetings with qualified investors throughout the conference.

The live webcast and subsequent archived recordings for the presentation can be accessed and on the investor relations section of the Milestone Scientific website at .

About Dawson James Securities

Dawson James Securities, Inc., a member of FINRA/SIPC, is a full-service investment bank headquartered in Boca Raton, FL. .

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS), a technology focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the or visit .

Contact: David Waldman or Natalya Rudman

Crescendo Communications, LLC

Email:

Tel: 212-671-1020



EN
18/10/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MILESTONE SCIENTIFIC

 PRESS RELEASE

Milestone Scientific Launches The Wand® Ambassador Program to Expand P...

Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry Pilot launched with six registered dental professionals; program expected to scale to 250 ambassadors over 12 months ROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the launch of The Wand® Ambassador Program, a scalable peer-to-peer engagement initiative designed to expand clinical awareness, educ...

 PRESS RELEASE

Milestone Scientific Delivers Stable Revenue and Reduces Operating Exp...

Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025 Company outlines continued progress executing operational transformation and growth strategy across its dental and medical segments ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced financial results and provided a business update for the third quarter ended September 30, 2025, highlighting continued ...

 PRESS RELEASE

Milestone Scientific Schedules Third Quarter 2025 Financial Results an...

Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 14th, 2025, to discuss the company’s financial results for the third quarter ended September 30, 2025, as well as the company’s corporate progress and other developments. The conference call will ...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: October 29, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Milestone Scientific Highlights Operational Progress and Growth Initia...

Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership Company outlines decisive initiatives to strengthen its dental and medical businesses, reduce operating expenses across the organization, and position Milestone Scientific for accelerated growth and improved financial performance ROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update highlighting the Company’s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch